Oarsman Capital’s STAAR Surgical STAA Stock Holding History

Oarsman Capital’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-793	Closed	-$29.5K	–	940
2024 Q3	$29.5K	Buy	+793	New	+$29.6K	0.01%	538

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RAM

Resona Asset Management Koto-Ku,tokyo, Japan $20.1B AUM 26.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Oarsman Capital's STAA Position: Q4 2024 in Review

Oarsman Capital sold out of STAAR Surgical (STAA) in Q4 2024, closing a stake of 793 shares — an estimated $29.5K sold.

Oarsman Capital first reported a position in STAA in Q3 2024 and held it in 1 quarter. The position peaked at $29.5K in Q3 2024. 212 funds tracked by Wall St. Rank hold STAA as of Q4 2024.

Oarsman Capital reported no remaining STAAR Surgical position as of Q4 2024 after selling out during the quarter.
Oarsman Capital sold 793 STAAR Surgical shares in Q4 2024, an estimated $29.5K.
Oarsman Capital first reported a position in STAAR Surgical in Q3 2024 and held it in 1 quarter.
Oarsman Capital's STAAR Surgical position peaked at $29.5K in Q3 2024.
212 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2024.

Based on Oarsman Capital's 13F filing for Q4 2024, filed 13 Feb 2025.